A systems biology approach to synovial joint lubrication in health, injury, and disease

Wiley Interdisciplinary Reviews: Systems Biology and Medicine

Volumn 4, Issue 1, 2012, Pages 15-37

  Hui, Alexander Y ^a   McCarty, William J ^a   Masuda, Koichi ^b   Firestein, Gary S ^b   Sah, Robert L ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE HYDROLASE;

ANIMAL; ARTHRITIS; BIOLOGICAL MODEL; CHEMISTRY; FEMALE; HUMAN; INJURY; JOINT; MALE; METABOLISM; METHODOLOGY; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEOMICS; RAT; REVIEW; SYNOVIAL FLUID; SYSTEMS BIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ARTHRITIS; BIOLOGICAL TRANSPORT; FEMALE; HUMANS; JOINTS; MALE; MICE; MODELS, BIOLOGICAL; PEPTIDE HYDROLASES; PROTEOMICS; RATS; SYNOVIAL FLUID; SYSTEMS BIOLOGY;

EID: 83755220457     PISSN: 19395094     EISSN: 1939005X     Source Type: Journal    
DOI: 10.1002/wsbm.157     Document Type: Review

References (188)

1. Ateshian GA, Mow VC. Friction, lubrication, and wear of articular cartilage and diarthrodial joints. In: Mow VC, Huiskes R, eds. Basic Orthopaedic Biomechanics and Mechano-Biology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2005, 447-494.
2. Ropes MW, Rossmeisl EC, Bauer W. The origin and nature of normal human synovial fluid. J Clin Invest 1940, 19:795-799.
3. Schumacher BL, Block JA, Schmid TM, Aydelotte MB, Kuettner KE. A novel proteoglycan synthesized and secreted by chondrocytes of the superficial zone of articular cartilage. Arch Biochem Biophys 1994, 311:144-152.
4. Jay GD, Britt DE, Cha CJ. Lubricin is a product of megakaryocyte stimulating factor gene expression by human synovial fibroblasts. J Rheumatol 2000, 27:594-600.
5. Meyer K, Smyth EM, Dawson MH. The isolation of a mucopolysaccharide from synovial fluid. J Biol Chem 1939, 128:319-327.
6. Hyc A, Osiecka-Iwan A, Niderla-Bielinska J, Jankowska-Steifer E, Moskalewski S. Pro- and anti-inflammatory cytokines increase hyaluronan production by rat synovial membrane in vitro. Int J Mol Med 2009, 24:579-585.
7. Goldring MB. Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2000, 2:459-465.
8. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007, 7:429-442.
9. Blewis ME, Lao BJ, Schumacher BL, Bugbee WD, Sah RL, Firestein GS. Interactive cytokine regulation of synoviocyte lubricant secretion. Tissue Eng Part A 2010, 16:1329-1337.
10. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29:1039-1049.
11. Neogi T, Aletaha D, Silman AJ, Naden RL, Felson DT, Aggarwal R, Bingham CO, 3rd, Birnbaum NS, Burmester GR, Bykerk VP, et al. The 2010 American College of Rheumatology/European League against rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum 2010, 62:2582-2591.
12. Wolfe F, Cush JJ, O'Dell JR, Kavanaugh A, Kremer JM, Lane NE, Moreland LW, Paulus HE, Pincus T, Russell AS, et al. Consensus recommendations for the assessment and treatment of rheumatoid arthritis. J Rheumatol 2001, 28:1423-1430.
13. Lotz MK, Kraus VB. New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options. Arthritis Res Ther 2010, 12:211.
14. Furman BD, Olson SA, Guilak F. The development of posttraumatic arthritis after articular fracture. J Orthop Trauma 2006, 20:719-725.
15. Anderson DD, Chubinskaya S, Guilak F, Martin JA, Oegema TR, Olson SA, Buckwalter JA. Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention. J Orthop Res: Off Publ Orthop Res Soc 2011, 29:802-809.
16. Schmid K, Macnair MB. Characterization of the proteins of human synovial fluid in certain disease states. J Clin Invest 1956, 35:814-824.
17. Schmid K, Macnair MB. Characterization of the proteins of certain postmortem human synovial fluids. J Clin Invest 1958, 37:708-718.
18. Holley HL, Patton FM, Pigman W, Platt D. An electrophoretic study of normal and post-mortem human and bovine synovial fluids. Arch Biochem Biophys 1956, 64:152-163.
19. Levick JR. Permeability of rheumatoid and normal human synovium to specific plasma proteins. Arthritis Rheum 1981, 24:1550-1560.
20. Schur PH, Sandson J. Immunologic studies of the proteins of human synovial fluid. Arthritis Rheum 1963, 6:115-129.
21. Decker B, McKenzie BF, McGuckin WF, Slocumb CH. Comparative distribution of proteins and glycoproteins of serum and synovial fluid. Arthritis Rheum 1959, 2:162-177.
22. Sitton NG, Dixon JS, Bird HA, Wright V. Serum and synovial fluid histidine: a comparison in rheumatoid arthritis and osteoarthritis. Rheumatol Int 1986, 6:251-254.
23. Shtacher G, Maayan R, Feinstein G. Proteinase inhibitors in human synovial fluid. Biochim Biophys Acta 1973, 303:138-147.
24. Ogston AG, Stanier JE. The physiological function of hyaluronic acid in synovial fluid: viscous, elastic and lubricant properties. J Phys 1953, 119:244-252.
25. Swann DA, Sotman S, Dixon M, Brooks C. The isolation and partial characterization of the major glycoprotein (LGP-I) from the articular lubricating fraction from bovine synovial fluid. Biochem J 1977, 161: 473-485.
26. Swann DA, Slayter HS, Silver FH. The molecular structure of lubricating glycoprotein-I, the boundary lubricant for articular cartilage. J Biol Chem 1981, 256:5921-5925.
27. Decker B, McGuckin WF, McKenzie BF, Slocumb CH. Concentration of hyaluronic acid in synovial fluid. Clin Chem 1959, 5:465-469.
28. Hamerman D, Schuster H. Hyaluronate in normal human synovial fluid. J Clin Investig 1958, 37:57-64.
29. Stafford CT, Niedermeier W, Holley HL, Pigman W. Studies on the concentration and intrinsic viscosity of hyaluronic acid in synovial fluids of patients with rheumatic diseases. Ann Rheum Dis 1964, 23: 152-157.
30. Schmid T, Lindley K, Su J, Soloveychik V, Block J, Kuettner K, Schumacher B. Superficial zone protein (SZP) is an abundant glycoprotein in human synovial fluid and serum. Trans Orthop Res Soc 2001, 26:82.
31. Elsaid KA, Fleming BC, Oksendahl HL, Machan JT, Fadale PD, Hulstyn MJ, Shalvoy R, Jay GD. Decreased lubricin concentrations and markers of joint inflammation in the synovial fluid of patients with anterior cruciate ligament injury. Arthritis Rheum 2008, 58:1707-1715.
32. Neu CP, Reddi AH, Komvopoulos K, Schmid TM, Di Cesare PE. Increased friction coefficient and superficial zone protein expression in patients with advanced osteoarthritis. Arthritis Rheum 2010, 62:2680-2687.
33. Lee HG, Cowman MK. An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Anal Biochem 1994, 219:278-287.
34. McDonald JN, Levick JR. Effect of intra-articular hyaluronan on pressure-flow relation across synovium in anaesthetized rabbits. J Physiol 1995, 485 (Pt 1): 179-193.
35. Jay GD, Harris DA, Cha CJ. Boundary lubrication by lubricin is mediated by O-linked β (1-3)Gal-GalNAc oligosaccharides. Glycoconj J 2001, 18:807-815.
36. Jay GD, Tantravahi U, Britt DE, Barrach HJ, Cha CJ. Homology of lubricin and superficial zone protein (SZP): products of megakaryocyte stimulating factor (MSF) gene expression by human synovial fibroblasts and articular chondrocytes localized to chromosome 1q25. J Orthop Res 2001, 19:677-687.
37. Gomez JE, Thurston GB. Comparisons of the oscillatory shear viscoelasticity and composition of pathological synovial fluids. Biorheology 1993, 30:409-427.
38. Bollet AJ. The intrinsic viscosity of synovial fluid hyaluronic acid. J Lab Clin Med 1956, 48:721-728.
39. Dahl LB, Dahl IM, Engstrom-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985, 44:817-822.
40. Swann DA, Radin EL, Nazimiec M, Weisser PA, Curran N, Lewinnek G. Role of hyaluronic acid in joint lubrication. Ann Rheum Dis 1974, 33:318-326.
41. Young AA, McLennan S, Smith MM, Smith SM, Cake MA, Read RA, Melrose J, Sonnabend DH, Flannery CR, Little CB. Proteoglycan 4 downregulation in a sheep meniscectomy model of early osteoarthritis. Arthritis Res Ther 2006, 8:R41.
42. Elsaid KA, Jay GD, Warman ML, Rhee DK, Chichester CO. Association of articular cartilage degradation and loss of boundary-lubricating ability of synovial fluid following injury and inflammatory arthritis. Arthritis Rheum 2005, 52:1746-1755.
43. Catterall JB, Stabler TV, Flannery CR, Kraus VB. Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254). Arthritis Res Ther 2010, 12:R229.
44. Jones AR, Chen S, Chai DH, Stevens AL, Gleghorn JP, Bonassar LJ, Grodzinsky AJ, Flannery CR. Modulation of lubricin biosynthesis and tissue surface properties following cartilage mechanical injury. Arthritis Rheum 2009, 60:133-142.
45. Marcelino J, Carpten JD, Suwairi WM, Gutierrez OM, Schwartz S, Robbins C, Sood R, Makalowska I, Baxevanis A, Johnstone B, et al. CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet 1999, 23:319-322.
46. Rhee DK, Marcelino J, Baker M, Gong Y, Smits P, Lefebvre V, Jay GD, Stewart M, Wang H, Warman ML, et al. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest 2005, 115:622-631.
47. Marks PH, Donaldson ML. Inflammatory cytokine profiles associated with chondral damage in the anterior cruciate ligament-deficient knee. Arthroscopy 2005, 21:1342-1347.
48. Cameron M, Buchgraber A, Passler H, Vogt M, Thonar E, Fu F, Evans CH. The natural history of the anterior cruciate ligament-deficient knee. Changes in synovial fluid cytokine and keratan sulfate concentrations. Am J Sports Med 1997, 25:751-754.
49. Cuellar VG, Cuellar JM, Golish SR, Yeomans DC, Scuderi GJ. Cytokine profiling in acute anterior cruciate ligament injury. Arthroscopy 2010, 26: 1296-1301.
50. Kahle P, Saal JG, Schaudt K, Zacher J, Fritz P, Pawelec G. Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis 1992, 51:731-734.
51. Richette P, Francois M, Vicaut E, Fitting C, Bardin T, Corvol M, Savouret JF, Rannou F. A high interleukin 1 receptor antagonist/IL-1β ratio occurs naturally in knee osteoarthritis. J Rheumatol 2008, 35: 1650-1654.
52. Horiuchi T, Yoshida T, Koshihara Y, Sakamoto H, Kanai H, Yamamoto S, Ito H. The increase of parathyroid hormone-related peptide and cytokine levels in synovial fluid of elderly rheumatoid arthritis and osteoarthritis. Endocr J 1999, 46:643-649.
53. Westacott CI, Whicher JT, Barnes IC, Thompson D, Swan AJ, Dieppe PA. Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis 1990, 49:676-681.
54. Lettesjo H, Nordstrom E, Strom H, Nilsson B, Glinghammar B, Dahlstedt L, Moller E. Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand J Immunol 1998, 48:286-292.
55. Nakanishi Y, Yamanaka H, Hakoda M, Nakazawa S, Saito S, Hara M, Kamatani N, Kashiwazaki S. Association between hypoxanthine concentration in synovial fluid and joint destruction in patients with rheumatoid arthritis. Mod Rheumatol 1998, 8:59-67.
56. Cameron ML, Fu FH, Paessler HH, Schneider M, Evans CH. Synovial fluid cytokine concentrations as possible prognostic indicators in the ACL-deficient knee. Knee Surg Sports Traumatol Arthrosc 1994, 2:38-44.
57. Irie K, Uchiyama E, Iwaso H. Intraarticular inflammatory cytokines in acute anterior cruciate ligament injured knee. Knee 2003, 10:93-96.
58. Pagura SM, Thomas SG, Woodhouse LJ, Ezzat S, Marks P. Circulating and synovial levels of IGF-I, cytokines, physical function and anthropometry differ in women awaiting total knee arthroplasty when compared to men. J Orthop Res 2005, 23:397-405.
59. Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M. Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 1989, 83:585-592.
60. Shao XT, Feng L, Gu LJ, Wu LJ, Feng TT, Yang YM, Wu NP, Yao HP. Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritis. Clin Exp Med 2009, 9:215-221.
61. Tchetverikov I, Lohmander LS, Verzijl N, Huizinga TW, TeKoppele JM, Hanemaaijer R, DeGroot J. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Ann Rheum Dis 2005, 64:694-698.
62. Ishiguro N, Ito T, Ito H, Iwata H, Jugessur H, Ionescu M, Poole AR. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover: analyses of synovial fluid from patients with osteoarthritis. Arthritis Rheum 1999, 42:129-136.
63. Dahlberg L, Friden T, Roos H, Lark MW, Lohmander LS. A longitudinal study of cartilage matrix metabolism in patients with cruciate ligament rupturesynovial fluid concentrations of aggrecan fragments, stromelysin-1 and tissue inhibitor of metalloproteinase-1. Br J Rheumatol 1994, 33:1107-1111.
64. Lohmander LS, Roos H, Dahlberg L, Hoerrner LA, Lark MW. Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus. J Orthop Res 1994, 12:21-28.
65. Lohmander LS, Atley LM, Pietka TA, Eyre DR. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum 2003, 48:3130-3139.
66. Levick JR, McDonald JN. Fluid movement across synovium in healthy joints: role of synovial fluid macromolecules. Ann Rheum Dis 1995, 54:417-423.
67. Binette JP, Schmid K. The proteins of synovial fluid: a study of the α1-α2 globulin ratio. Arthritis Rheum 1965, 8:14-28.
68. Steiner G, Studnicka-Benke A, Witzmann G, Hofler E, Smolen J. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis. J Rheumatol 1995, 22:406-412.
69. Belcher C, Yaqub R, Fawthrop F, Bayliss M, Doherty M. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees. Ann Rheum Dis 1997, 56:299-307.
70. Larsson S, Lohmander LS, Struglics A. Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study. Arthritis Res Ther 2009, 11:R92.
71. Lohmander LS, Saxne T, Heinegard DK. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis 1994, 53:8-13.
72. Doss F, Menard J, Hauschild M, Kreutzer HJ, Mittlmeier T, Muller-Steinhardt M, Muller B. Elevated IL-6 levels in the synovial fluid of osteoarthritis patients stem from plasma cells. Scand J Rheumatol 2007, 36:136-139.
73. Futani H, Okayama A, Matsui K, Kashiwamura S, Sasaki T, Hada T, Nakanishi K, Tateishi H, Maruo S, Okamura H. Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation. J Immunother 2002, 25 (Suppl 1):S61-S64.
74. Malemud CJ. Anticytokine therapy for osteoarthritis: evidence to date. Drugs Aging 2010, 27:95-115.
75. Elsaid KA, Machan JT, Waller K, Fleming BC, Jay GD. The impact of anterior cruciate ligament injury on lubricin metabolism and the effect of inhibiting tumor necrosis factor α on chondroprotection in an animal model. Arthritis Rheum 2009, 60:2997-3006.
76. Poole AR. Cartilage in health and disease. In: Koopman WJ, ed. Arthritis and Allied Conditions., Vol. 1. 15th ed. Philadelphia: Lippincott, Williams and Wilkins; 2005, 1:223-269.
77. Dahlberg L, Friden T, Roos H, Lark MW, Lohmander LS. Longitudinal-study of cartilage matrix metabolism in patients with cruciate ligament rupture-synovial-fluid concentrations of aggrecan fragments, stromelysin-1 and tissue inhibitor of metalloproteinase-1. Brit J Rheumatol 1994, 33:1107-1111.
78. Coggeshall HC, Warren CF, Bauer W. The cytology of normal human synovial fluid. Anat Rec 1940, 77:129-144.
79. McEwen C. Cytologic studies on rheumatic fever: II. cells of rheumatic exudates. J Clin Invest 1935, 14:190-201.
80. Fye KH. Arthrocentesis, synovial fluid analysis, and synovial biopsy. In: Klippel JH, Stone JH, Crofford LJ, White PH, eds. Primer on the Rheumatic Diseases. 13th ed. Atlanta: Arthritis Foundation; 2008, 21-27.
81. Kratz A, Pesce MA, Fink DJ. Appendix: laboratory values of clinical importance. In: Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Jameson J, Loscalzo J, eds. Harrison's Principles of Internal Medicine, New York: McGraw-Hill Medical; 2008, 17e. Available at: (Accessed July 6, 2011).
82. Krey PR, Bailen DA. Synovial fluid leukocytosis. A study of extremes. Am J Med 1979, 67:436-442.
83. Firestein GS. Etiology and pathogenesis of rheumatoid arthritis. In: Firestein GS, ed. Kelley's Textbook of Rheumatology. 8th ed. Philadelphia: Elsevier; 2009, 1035-1086.
84. Schumacher BL, Hughes CE, Kuettner KE, Caterson B, Aydelotte MB. Immunodetection and partial cDNA sequence of the proteoglycan, superficial zone protein, synthesized by cells lining synovial joints. J Orthop Res 1999, 17:110-120.
85. Schumacher BL, Schmidt TA, Voegtline MS, Chen AC, Sah RL. Proteoglycan 4 (PRG4) synthesis and immunolocalization in bovine meniscus. J Orthop Res 2005, 23:562-568.
86. Sabaratnam S, Arunan V, Coleman PJ, Mason RM, Levick JR. Size selectivity of hyaluronan molecular sieving by extracellular matrix in rabbit synovial joints. J Physiol 2005, 567:569-581.
87. Simkin PA. Synovial permeability in rheumatoid arthritis. Arthritis Rheum 1979, 22:689-696.
88. Levick JR, McDonald JN. Ultrastructure of transport pathways in stressed synovium of the knee in anaesthetized rabbits. J Physiol 1989, 419:493-508.
89. Granger HJ, Taylor AE. Permeability of connective tissue linings isolated from implanted capsules; implications for interstitial pressure measurements. Circ Res 1975, 36:222-228.
90. Sabaratnam S, Coleman PJ, Mason RM, Levick JR. Interstitial matrix proteins determine hyaluronan reflection and fluid retention in rabbit joints: effect of protease. J Physiol 2007, 578:291-299.
91. Kushner I, Somerville JA. Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation. Arthritis Rheum 1971, 14:560-570.
92. Pejovic M, Stankovic A, Mitrovic DR. Determination of the apparent synovial permeability in the knee joint of patients suffering from osteoarthritis and rheumatoid arthritis. Br J Rheumatol 1995, 34:520-524.
93. Safari M, Bjelle A, Gudmundsson M, Hogfors C, Granhed H. Clinical assessment of rheumatic diseases using viscoelastic parameters for synovial fluid. Biorheology 1990, 27:659-674.
94. Schurz J, Ribitsch V. Rheology of synovial fluid. Biorheology 1987, 24:385-399.
95. Fam H, Bryant JT, Kontopoulou M. Rheological properties of synovial fluids. Biorheology 2007, 44:59-74.
96. Jay GD, Torres JR, Warman ML, Laderer MC, Breuer KS. The role of lubricin in the mechanical behavior of synovial fluid. Proc Natl Acad Sci U S A 2007, 104:6194-6199.
97. Schmidt TA, Gastelum NS, Nguyen QT, Schumacher BL, Sah RL. Boundary lubrication of articular cartilage: role of synovial fluid constituents. Arthritis Rheum 2007, 56:882-891.
98. Schmidt TA, Sah RL. Effect of synovial fluid on boundary lubrication of articular cartilage. Osteoarthritis Cartilage 2007, 15:35-47.
99. Gleghorn JP, Jones AR, Flannery CR, Bonassar LJ. Boundary mode lubrication of articular cartilage by recombinant human lubricin. J Orthop Res 2009, 27:771-777.
100. Teeple E, Elsaid KA, Fleming BC, Jay GD, Aslani K, Crisco JJ, Mechrefe AP. Coefficients of friction, lubricin, and cartilage damage in the anterior cruciate ligament-deficient guinea pig knee. J Orthop Res 2007, 26:231-237.
101. Jay GD, Elsaid KA, Zack J, Robinson K, Trespalacios F, Cha CJ, Chichester CO. Lubricating ability of aspirated synovial fluid from emergency department patients with knee joint synovitis. J Rheumatol 2004, 31:557-564.
102. Momberger TS, Levick JR, Mason RM. Hyaluronan secretion by synoviocytes is mechanosensitive. Matrix Biol 2005, 24:510-519.
103. Ingram KR, Wann AK, Angel CK, Coleman PJ, Levick JR. Cyclic movement stimulates hyaluronan secretion into the synovial cavity of rabbit joints. J Physiol 2008, 586:1715-1729.
104. Grad S, Lee CR, Gorna K, Gogolewski S, Wimmer MA, Alini M. Surface motion upregulates superficial zone protein and hyaluronan production in chondrocyte-seeded three-dimensional scaffolds. Tissue Eng 2005, 11:249-256.
105. Nugent GE, Aneloski NM, Schmidt TA, Schumacher BL, Voegtline MS, Sah RL. Dynamic shear stimulation of bovine cartilage biosynthesis of proteoglycan 4 (PRG4). Arthritis Rheum 2006, 54:1888-1896.
106. Grad S, Gogolewski S, Alini M, Wimmer MA. Effects of simple and complex motion patterns on gene expression of chondrocytes seeded in 3D scaffolds. Tissue Eng 2006, 12:3171-3179.
107. Wimmer MA, Alini M, Grad S. The effect of sliding velocity on chondrocytes activity in 3D scaffolds. J Biomech 2009, 42:424-429.
108. Neu CP, Khalafi A, Komvopoulos K, Schmid TM, Reddi AH. Mechanotransduction of bovine articular cartilage superficial zone protein by transforming growth factor β signaling. Arthritis Rheum 2007, 56:3706-3714.
109. Nugent-Derfus GE, Takara T, O'Neill JK, Cahill SB, Gortz S, Pong T, Inoue H, Aneloski NM, Wang WW, Vega KI, et al. Continuous passive motion applied to whole joints stimulates chondrocyte biosynthesis of PRG4. Osteoarthritis Cartilage 2007, 15:566-574.
110. McCarty WJ, Nguyen QT, Hui AY, Chen AC, Sah RL. Synovial joints: mechanobiology and tissue engineering of articular cartilage and synovial fluid. In: Ducheyne P, Healy KE, Hutmacher DE, Grainger DE, Kirkpatrick CJ, eds. Comprehensive Biomaterials. 1st ed; 2011.
111. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010, 6:625-635.
112. Badot V, Galant C, Nzeusseu Toukap A, Theate I, Maudoux AL, Van den Eynde BJ, Durez P, Houssiau FA, Lauwerys BR. Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis. Arthritis Res Ther 2009, 11:R57.
113. Dehne T, Karlsson C, Ringe J, Sittinger M, Lindahl A. Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation. Arthritis Res Ther 2009, 11:R133.
114. Pohlers D, Beyer A, Koczan D, Wilhelm T, Thiesen HJ, Kinne RW. Constitutive upregulation of the transforming growth factor-β pathway in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 2007, 9:R59.
115. Rockel JS, Bernier SM, Leask A. Egr-1 inhibits the expression of extracellular matrix genes in chondrocytes by TNFα-induced MEK/ERK signalling. Arthritis Res Ther 2009, 11:R8.
116. Sandell LJ, Xing X, Franz C, Davies S, Chang LW, Patra D. Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1β. Osteoarthritis Cartilage 2008, 16:1560-1571.
117. Andreas K, Haupl T, Lubke C, Ringe J, Morawietz L, Wachtel A, Sittinger M, Kaps C. Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther 2009, 11:R15.
118. Andreas K, Lubke C, Haupl T, Dehne T, Morawietz L, Ringe J, Kaps C, Sittinger M. Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study. Arthritis Res Ther 2008, 10:R9.
119. Lequerre T, Bansard C, Vittecoq O, Derambure C, Hiron M, Daveau M, Tron F, Ayral X, Biga N, Auquit-Auckbur I, et al. Early and long-standing rheumatoid arthritis: distinct molecular signatures identified by gene-expression profiling in synovia. Arthritis Res Ther 2009, 11:R99.
120. Huber R, Hummert C, Gausmann U, Pohlers D, Koczan D, Guthke R, Kinne RW. Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane. Arthritis Res Ther 2008, 10:R98.
121. Arora PS, Yamagiwa H, Srivastava A, Bolander ME, Sarkar G. Comparative evaluation of two two-dimensional gel electrophoresis image analysis software applications using synovial fluids from patients with joint disease. J Orthop Sci 2005, 10:160-166.
122. Firestein GS, Pisetsky DS. DNA microarrays: Boundless technology or bound by technology? Guidelines for studies using microarray technology. Arthritis Rheum 2002, 46:859-861.
123. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001, 98: 5116-5121.
124. van der Pouw Kraan TC, van Gaalen FA, Huizinga TW, Pieterman E, Breedveld FC, Verweij CL. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immun 2003, 4:187-196.
125. van der Pouw Kraan TC, van Gaalen FA, Kasper- kovitz PV, Verbeet NL, Smeets TJ, Kraan MC, Fero M, Tak PP, Huizinga TW, Pieterman E, et al. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 2003, 48:2132-2145.
126. Kasperkovitz PV, Timmer TC, Smeets TJ, Verbeet NL, Tak PP, van Baarsen LG, Baltus B, Huizinga TW, Pieterman E, Fero M, et al. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum 2005, 52:430-441.
127. Fitzgerald JB, Jin M, Dean D, Wood DJ, Zheng MH, Grodzinsky AJ. Mechanical compression of cartilage explants induces multiple time-dependent gene expression patterns and involves intracellular calcium and cyclic AMP. J Biol Chem 2004, 279:19502-19511.
128. Fitzgerald JB, Jin M, Grodzinsky AJ. Shear and compression differentially regulate clusters of functionally related temporal transcription patterns in cartilage tissue. J Biol Chem 2006, 281:24095-24103.
129. Lee JH, Fitzgerald JB, Dimicco MA, Grodzinsky AJ. Mechanical injury of cartilage explants causes specific time-dependent changes in chondrocyte gene expression. Arthritis Rheum 2005, 52:2386-2395.
130. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005, 102:15545-15550.
131. Karlsson C, Dehne T, Lindahl A, Brittberg M, Pruss A, Sittinger M, Ringe J. Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis. Osteoarthritis Cartilage 2010, 18:581-592.
132. Appleton CT, Pitelka V, Henry J, Beier F. Global analyses of gene expression in early experimental osteoarthritis. Arthritis Rheum 2007, 56:1854-1868.
133. Gebauer M, Saas J, Haag J, Dietz U, Takigawa M, Bartnik E, Aigner T. Repression of anti-proliferative factor Tob1 in osteoarthritic cartilage. Arthritis Res Ther 2005, 7:R274-R284.
134. Hermansson M, Sawaji Y, Bolton M, Alexander S, Wallace A, Begum S, Wait R, Saklatvala J. Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin βA (activin A), a regulatory molecule for chondrocytes. J Biol Chem 2004, 279:43514-43521.
135. Wu J, Liu W, Bemis A, Wang E, Qiu Y, Morris EA, Flannery CR, Yang Z. Comparative proteomic characterization of articular cartilage tissue from normal donors and patients with osteoarthritis. Arthritis Rheum 2007, 56:3675-3684.
136. Kabuyama Y, Kitamura T, Yamaki J, Homma MK, Kikuchi S, Homma Y. Involvement of thioredoxin reductase 1 in the regulation of redox balance and viability of rheumatoid synovial cells. Biochem Biophys Res Commun 2008, 367:491-496.
137. Gallagher J, Howlin J, McCarthy C, Murphy EP, Bresnihan B, FitzGerald O, Godson C, Brady HR, Martin F. Identification of Naf1/ABIN-1 among TNF-α-induced expressed genes in human synoviocytes using oligonucleotide microarrays. FEBS Lett 2003, 551:8-12.
138. Honda T, Segi-Nishida E, Miyachi Y, Narumiya S. Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J Exp Med 2006, 203:325-335.
139. Haag J, Gebhard PM, Aigner T. SOX gene expression in human osteoarthritic cartilage. Pathobiology 2008, 75:195-199.
140. Aigner T, Zien A, Hanisch D, Zimmer R. Gene expression in chondrocytes assessed with use of microarrays. J Bone Joint Surg Am 2003, 2:117-123.
141. Sato T, Konomi K, Yamasaki S, Aratani S, Tsuchimochi K, Yokouchi M, Masuko-Hongo K, Yagishita N, Nakamura H, Komiya S, et al. Comparative analysis of gene expression profiles in intact and damaged regions of human osteoarthritic cartilage. Arthritis Rheum 2006, 54:808-817.
142. Dell'accio F, De Bari C, Eltawil NM, Vanhummelen P, Pitzalis C. Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis. Arthritis Rheum 2008, 58:1410-1421.
143. Kamphorst JJ, van der Heijden R, DeGroot J, Lafeber FP, Reijmers TH, van El B, Tjaden UR, van der Greef J, Hankemeier T. Profiling of endogenous peptides in human synovial fluid by NanoLC-MS: method validation and peptide identification. J Proteome Res 2007, 6:4388-4396.
144. Sinz A, Bantscheff M, Mikkat S, Ringel B, Drynda S, Kekow J, Thiesen HJ, Glocker MO. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 2002, 23:3445-3456.
145. Gobezie R, Kho A, Krastins B, Sarracino DA, Thornhill TS, Chase M, Millett PJ, Lee DM. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther 2007, 9:R36.
146. Liao H, Wu J, Kuhn E, Chin W, Chang B, Jones MD, O'Neil S, Clauser KR, Karl J, Hasler F, et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 2004, 50:3792-3803.
147. Drynda S, Ringel B, Kekow M, Kuhne C, Drynda A, Glocker MO, Thiesen HJ, Kekow J. Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFα therapy. Pathol Res Pract 2004, 200:165-171.
148. Ruiz-Romero C, Lopez-Armada MJ, Blanco FJ. Proteomic characterization of human normal articular chondrocytes: a novel tool for the study of osteoarthritis and other rheumatic diseases. Proteomics 2005, 5:3048-3059.
149. Cillero-Pastor B, Ruiz-Romero C, Carames B, Lopez-Armada MJ, Blanco FJ. Proteomic analysis by two-dimensional electrophoresis to identify the normal human chondrocyte proteome stimulated by tumor necrosis factor α and interleukin-1β. Arthritis Rheum 2010, 62:802-814.
150. De Ceuninck F, Marcheteau E, Berger S, Caliez A, Dumont V, Raes M, Anract P, Leclerc G, Boutin JA, Ferry G. Assessment of some tools for the characterization of the human osteoarthritic cartilage proteome. J Biomol Tech 2005, 16:256-265.
151. Stevens AL, Wishnok JS, Chai DH, Grodzinsky AJ, Tannenbaum SR. A sodium dodecyl sulfate-polyacrylamide gel electrophoresis-liquid chromatography tandem mass spectrometry analysis of bovine cartilage tissue response to mechanical compression injury and the inflammatory cytokines tumor necrosis factor α and interleukin-1β. Arthritis Rheum 2008, 58:489-500.
152. Rosenthal AK, Gohr CM, Ninomiya J, Wakim BT. Proteomic analysis of articular cartilage vesicles from normal and osteoarthritic cartilage. Arthritis Rheum 2011, 63:401-411.
153. Ruiz-Romero C, Lopez-Armada MJ, Blanco FJ. Mitochondrial proteomic characterization of human normal articular chondrocytes. Osteoarthritis Cartilage 2006, 14:507-518.
154. Vincourt JB, Lionneton F, Kratassiouk G, Guillemin F, Netter P, Mainard D, Magdalou J. Establishment of a reliable method for direct proteome characterization of human articular cartilage. Mol Cell Proteomics 2006, 5:1984-1995.
155. Dasuri K, Antonovici M, Chen K, Wong K, Standing K, Ens W, El-Gabalawy H, Wilkins JA. The synovial proteome: analysis of fibroblast-like synoviocytes. Arthritis Res Ther 2004, 6:R161-R168.
156. Bo GP, Zhou LN, He WF, Luo GX, Jia XF, Gan CJ, Chen GX, Fang YF, Larsen PM, Wu J. Analyses of differential proteome of human synovial fibroblasts obtained from arthritis. Clin Rheumatol 2009, 28:191-199.
157. Tilleman K, Van Beneden K, Dhondt A, Hoffman I, De Keyser F, Veys E, Elewaut D, Deforce D. Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry. Proteomics 2005, 5:2247-2257.
158. Lorenz P, Ruschpler P, Koczan D, Stiehl P, Thiesen HJ. From transcriptome to proteome: differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies. Proteomics 2003, 3:991-1002.
159. Fell HB. Synoviocytes. J Clin Pathol Suppl (R Coll Pathol) 1978, 12:14-24.
160. Dingle JT, Saklatvala J, Hembry R, Tyler J, Fell HB, Jubb R. A cartilage catabolic factor from synovium. Biochem J 1979, 184:177-180.
161. Haubeck HD, Kock R, Fischer DC, Van de Leur E, Hoffmeister K, Greiling H. Transforming growth factor β1, a major stimulator of hyaluronan synthesis in human synovial lining cells. Arthritis Rheum 1995, 38:669-677.
162. Recklies AD, White C, Melching L, Roughley PJ. Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem J 2001, 354:17-24.
163. Kawakami M, Suzuki K, Matsuki Y, Ishizuka T, Hidaka T, Konishi T, Matsumoto M, Kataharada K, Nakamura H. Hyaluronan production in human rheumatoid fibroblastic synovial lining cells is increased by interleukin 1β but inhibited by transforming growth factor β1. Ann Rheum Dis 1998, 57: 602-605.
164. Stuhlmeier KM, Pollaschek C. Differential effect of transforming growth factor β (TGF-β) on the genes encoding hyaluronan synthases and utilization of the p38 MAPK pathway in TGF-β-induced hyaluronan synthase 1 activation. J Biol Chem 2004, 279: 8753-8760.
165. Lee SY, Niikura T, Reddi AH. Superficial zone protein (lubricin) in the different tissue compartments of the knee joint: modulation by transforming growth factor β1 and interleukin-1β. Tissue Eng Part A 2008, 14:1799-1808.
166. Hardingham TE, Bayliss MT, Rayan V, Noble DP. Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage. Br J Rheum 1992, 31S1:1-6.
167. Chiroiu V, Mosnegutu V, Munteanu L, Ioan R. On a micromorphic model for the synovial fluid in the human knee. Mech Res Commun 2010, 37:246-255.
168. Nigam KM, Manohar K, Chaudhry KK. Viscoelastic fluid film lubrication with reference to human joints. Wear 1981, 70:63-75.
169. Ogston AG, Stanier JE, Toms BA, Strawbridge DJ. Elastic properties of ox synovial fluid. Nature 1950, 165:571.
170. Rainer F, Ribitsch V, Ulreich A. Viscosity of synovial fluid and possible artificial lubricants (author's transl). Acta Med Austriaca 1980, 7:92-95.
171. Tandon PN, Bong NH, Kushwaha K. A new model for synovial joint lubrication. Int J Biomed Comput 1994, 35:125-140.
172. Charnley J. The lubrication of animal joints in relation to surgical reconstruction by arthroplasty. Ann Rheum Dis 1960, 19:10-19.
173. MacConaill MA. The function of intna-anticular fibrocartilages, with special reference to the knee and inferior radio-ulnar joints. J Anat 1932, 66:210-227.
174. Walker PS, Dowson D, Longfield MD, Wright V. Boosted lubrication in synovial joints by fluid entrapment and enrichment. Ann Rheum Dis 1968, 27:512-520.
175. Maroudas A. Physicochemical properties of cartilage in the light of ion exchange theory. Biophys J 1968, 8:575-595.
176. DiMicco MA, Sah RL. Dependence of cartilage matrix composition on biosynthesis, diffusion, and reaction. Trans Porous Med 2003, 50:57-73.
177. Hascall VC, Luyten FP, Plaas AHK, Sandy JD. Steady-state metabolism of proteoglycans in bovine articular cartilage. In: Maroudas A, Kuettner K, eds. Methods in Cartilage Research. San Diego: Academic Press; 1990, 108-112.
178. Klein TJ, Sah RL. Modulation of depth-dependent properties in tissue-engineered cartilage with a semi-permeable membrane and perfusion: a continuum model of matrix metabolism and transport. Biomech Model Mechanobiol 2007, 6:21-32.
179. Maroudas A. Distribution and diffusion of solutes in articular cartilage. Biophys J 1970, 10:365-379.
180. Torzilli PA, Mow VC. On the fundamental fluid transport mechanisms through normal and pathological articular cartilage during function-I. The formulation. J Biomech 1976, 9:541-552.
181. Torzilli PA, Mow VC. On the fundamental fluid transport mechanisms through normal and pathological articular cartilage during function-II. The analysis, solution, and conclusions. J Biomech 1976, 9: 587-606.
182. Zhang L, Gardiner BS, Smith DW, Pivonka P, Grodzinsky A. The effect of cyclic deformation and solute binding on solute transport in cartilage. Arch Biochem Biophys 2007, 457:47-56.
183. Levick JR. An analysis of the effect of synovial capillary distribution upon trans-synovial concentration profiles and exchange. Q J Exp Physiol 1984, 69:289-300.
184. Levick JR. Blood flow and mass transport in synovial joints. In: Renkin M Michel C, eds. Handbook of Physiology, Section 2, The Cardiovascular System, Volume IV, The Microcirculation. Bethesda, MD: The American Physiological Society; 1984, 917-947.
185. Levick JR. An analysis of the interaction between interstitial plasma protein, interstitial flow, and fenestral filtration and its application to synovium. Microvasc Res 1994, 47:90-125.
186. Levick JR. A method for estimating macromolecular reflection by human synovium, using measurements of intra-articular half-lives. Ann Rheum Dis 1998, 57:339-344.
187. Blewis ME, Nugent-Derfus GE, Schmidt TA, Schumacher BL, Sah RL. A model of synovial fluid lubricant composition in normal and injured joints. Eur Cell Mater 2007, 13:26-39.
188. Rullmann JA, Struemper H, Defranoux NA, Ramanujan S, Meeuwisse CM, van Elsas A. Systems biology for battling rheumatoid arthritis: application of the Entelos PhysioLab platform. Syst Biol (Stevenage) 2005, 152:256-262.